EastPharma Ltd. GDR | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,062.40
1,550.20
11,320.00
18,467.50
27,822.40
34,162.30
Depreciation, Depletion & Amortization
19,388.30
17,612.90
15,074.30
14,905.50
9,437.10
7,632.50
Other Funds
1,209.00
3,948.00
17,167.30
11,168.00
13,278.30
31,960.70
Funds from Operations
21,659.70
20,010.70
43,561.60
49,498.70
51,685.90
73,755.50
Changes in Working Capital
2,557.00
12,730.10
20,823.30
4,638.70
34,094.50
54,985.30
Net Operating Cash Flow
19,102.70
7,280.60
22,738.30
44,860.00
17,591.40
18,770.20
Capital Expenditures
42,452.80
34,405.90
28,537.90
31,178.90
36,556.80
Sale of Fixed Assets & Businesses
8,208.00
628.70
328.50
570.50
4,516.80
Net Investing Cash Flow
33,178.80
33,195.10
28,209.40
30,608.40
32,040.10
Issuance/Reduction of Debt, Net
32,152.30
16,329.30
3,236.90
19,601.20
25,890.60
Net Financing Cash Flow
32,152.30
16,329.30
3,236.90
19,601.20
25,890.60
Net Change in Cash
15,851.00
10,685.70
7,470.50
3,404.60
12,372.20
Free Cash Flow
7,674.80
7,745.60
9,725.80
29,722.20
5,168.50
Deferred Taxes & Investment Tax Credit
-
-
-
4,957.60
1,148.00
-
Other Sources
1,066.00
582.10
-
-
-
Exchange Rate Effect
2,225.30
1,100.50
1,237.50
1,945.10
930.30
About EastPharma
View Profile
